Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With PCORI Methods Approved, Attention Shifts To Implementation

Executive Summary

At its November meeting, the Patient-Centered Outcomes Research Institute’s board of governors approves revisions to the methodological standards for patient-centered outcomes research found in the Methodology Committee report. The board also begins a dialogue on how the standards will be integrated into the funding and research process.

You may also be interested in...



Concerns About Pharma-Sponsored Research Removed From PCORI Methodology Report

The approved version of the Patient-Centered Outcomes Research Institute’s Methodology Report strikes language that questioned the trustworthiness of pharmaceutical industry-generated research.

Antibiotics Go Head-To-Head In PCORI-Funded Observational Study

Patient-Centered Outcomes Research Institute selected five drug-related research topics for funding, including a look at narrow- versus broad-spectrum antibiotics for acute respiratory tract infections in children, though all studies are observational. PCORI approved 52 CER projects in this third funding round, including many declined in the first round.

Leaving Little To The Imagination: PCORI Methods Report Emphasizes Transparency

The much-anticipated report says researchers should participate in study registries and share study protocols and data; PCORI is stepping up efforts to understand how health IT might best intersect with outcomes research.

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel